SEC Form 4 · accession 0001209191-16-112630
BG Medicine, Inc. · BGMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Aram S. Adourian
Officer — SVP & Chief Scientific Officer
Period of report
Mar 31, 2016
Accepted (ET)
Apr 4, 2016 · 8:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001407038
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Mar 31, 2016 | F | 7,456 | $0.36 | D | 35,770 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Relates to shares withheld for payment of tax liability upon vesting of restricted stock units ("RSUs"). The RSUs were granted on October 16, 2014 and vested as to the remaining 50% of the shares on March 31, 2016 resulting in a net issuance to the holder of 12,269 shares on March 31, 2016.
- F2Represents 35,770 shares of common stock and 0 RSUs.
Remarks
Note: The share numbers reflect the 1-for-4 reverse stock split of the common stock on July 8, 2015.